Progranulin (GRN) gene variability has been analyzed in a sample of 354 patients with multiple sclerosis (MS) compared with 343 controls. No significant differences were observed, but by stratifying according to MS subtypes, a significant increased frequency of the rs2879096 TT genotype was found in primary progressive MS (PPMS) patients versus controls (16.0 vs 3.5%, P ¼ 0.023, odds ratio (OR) 5.2, 95% confidence interval (CI) 1.2-21.4). In addition, in PPMS, an association with the C allele of rs4792938 was observed (55.3 vs 33.5%, P ¼ 0.011, OR 2.4, 95% CI 1.2-4.7). An independent population was studied as replication, failing to confirm results previously obtained. Stratifying according to gender, an association with rs4792938 C allele was found in male PPMS patients compared with controls (40.7 vs 26.9%, P ¼ 0.002, OR 1.87, 95% CI 1.2-2.8). An association with the rs2879096T allele was observed (29.2 in patients compared with 18.9% in controls, P ¼ 0.012, OR 1.77, 95% CI 1.1-2.8). Haplotype analysis showed that TC haplotype frequency is increased in PPMS male patients compared with male controls (25.7 vs 16.6%; P ¼ 0.02, OR 1.69, 95% CI 1.1-2.7), whereas the respective GC haplotype seems to exert a protective effect, as its frequency is decreased in patients compared with controls (55.8% vs 70.9%; P ¼ 0.001, OR 0.52, 95% CI 0.4-0.8). Therefore, GRN haplotypes likely influence the risk of developing PPMS in males.
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Introduction
Progranulin, a 593-amino acid secreted glycoprotein, has recently attracted the attention of the scientific community because of the discovery of mutations in its encoding gene (GRN) responsible for familial frontotemporal lobar degeneration (FTLD). It has a role in anti-inflammatory processes, but it can be proteolitically cleaved in granulins, which, conversely, act as proinflammatory mediators. 1 In adult central nervous system, GRN mRNA is expressed in forebrain, olfactory bulbs and spinal cord. 2 Other evidence can be found about increased levels of GRN mRNA in several inflammatory neurodegenerative disorders associated with microglial activation, such as amyotrophic lateral sclerosis 3 and virally induced central nervous system inflammation. 4 A contribution of GRN variability has also been previously shown in sporadic FTLD, 5, 6 although another study did not confirm these data. 7 GRN haplotypes influence the risk of developing Alzheimer's disease 8 as well as the age at onset and the duration of survival in patients with amyotrophic lateral sclerosis, 9 whereas GRN variability has likely no major role in susceptibility to Parkinson's disease. 10 Multiple sclerosis (MS) is considered predominantly an inflammatory autoimmune disease of the central nervous system, with myelin proteins supposed to act as autoantigens, starting with aberrant activation of specific populations of autoreactive T lymphocytes in the periphery, followed by T-cell recruitment into the brain. 11 This process leads to the activation of several inflammatory molecules, which in turn cause demyelination, eventually resulting in axonal damage. 12 Nevertheless, in primary progressive MS (PPMS) forms, neurodegeneration is prominent, as shown by the development of motor disability, cognitive deficits and brain atrophy. Moreover, several data support the concept that gray matter pathology may precede white matter pathology and occurs in part independently. 13 This makes conceivable that proteins already shown to be involved in more typical neurodegenerative diseases can have a role in the pathogenesis of MS.
Neuronal death is the pathological correlate of disease progression in MS, but the molecular mechanisms underlying neurodegeneration are not completely understood. Pathological events occurring during the development of neurodegenerative disorders could also have a role in MS. For instance, abnormal hyperphosphorylation of tau protein, an axonal cytoskeletal protein involved in microtubule assembly and stabilization, is implicated in the etiopathogenesis of FTLD, but there is an emerging evidence of tau-positive inclusions also in chronic progressive MS.
14 Therefore, an implication of progranulin in MS could be conceivable.
Given these premises, we carried out an association analysis of GRN in a sample of 354 patients with different subtypes of MS compared with 343 controls. Results obtained were replicated in a large independent sample of 224 PPMS, the subtype of the disease with a more prominent neurodegenerative component, compared with 233 controls.
Results
Four tagging single-nucleotide polymorphisms (SNPs) covering the entire GRN sequence were chosen ( Figure 1) . A minimum of one SNP per linkage disequilibrium (LD) block or two SNPs per haplotype blocks were prioritized as described previously. 6 Both control and case samples were in Hardy-Weinberg equilibrium for all SNPs studied. A trend towards an increased frequency of the rs2879096 TT genotype was observed in patients with MS when compared with controls (P ¼ 0.055, Table 1 Given the small number of PPMS studied, we carried out a replication analysis in a large independent sample of PPMS patients and in age-and gender-matched controls. The replication analysis failed to confirm results previously obtained regarding rs2879096 and rs4792938 on the whole PPMS population (Table 2) . Nevertheless, by stratifying PPMS patients and controls according to gender, an association with the rs4792938 C allele was found in male, but not female, patients, versus controls Table 3 ). In addition, an association with the rs2879096T allele was observed (29.2% in patients when compared with 18.9% in controls, P ¼ 0.012, OR 1.77, 95% CI 1.1-2.8, Table 3 ). Regarding haplotype analysis, the two SNPs associated with PPMS in male sample had a D' of 0.81 (95% CI 0.7-0.9) and, according to the method implemented in Haploview, 15 they were not recognized as the LD block (Figures 2a and b) . However, when the two SNPs were analyzed together as a block by using the 'customize' LD block definition option, the combination TC was found to be more frequent in cases than controls (25.7% vs 16.6%; P ¼ 0.02, OR 1.69, 95% CI 1.1-2.7, Table 4 ), whereas the CG haplotype showed the opposite trend, as it was found to be more frequent in controls than cases (70.9% vs 55.8%; P ¼ 0.001, OR 0.52, 95% CI 0.4-0.8, Table 4 ). The same haplotype analysis performed in female cases and controls showed a tendency toward a decreased frequency of the combination CC in cases compared with controls (10% vs 16.6%; P ¼ 0.035). However, the bootstrap P-values calculated using 100 000 bootstrap samples showed only in this case a P40.05, suggesting that this result would be not representative of a real association, possibly because of the fact that the population analyzed is not large enough to detect a significant association for this combination.
Furthermore, the association was retested by including the sex-genotype interaction term 16 in the logistic regression and after the correction for age. Results confirmed the significant association for both variants (rs2879096*gender: OR 1.86, 95% CI 1.0-3.4; rs4792938*gender: OR 2.54, 95% CI 1.5-4.4).
Discussion
Progranulin gene variability has been analyzed in a first population of MS patients compared with controls. A significant increased frequency of the rs2879096 TT genotype was found in PPMS patients versus controls. 
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A replication independent MS population tested to confirm these results failed to show the correlation. Nevertheless, a post hoc analysis performed on the replication population allowed to discover significant gender difference between cases and controls for the tested haplotype. In particular, according to these results, the GRN TC haplotype confers a significantly increased risk of developing PPMS in male sample, whereas the respective GRN CG haplotype seems to exert a protective role in reducing the risk of developing the disease (OR 0.52, 95% CI 0.4-0.8). It is interesting to note that the CG haplotype is even more significant than the susceptible TC, suggesting that the signal from rs4792938 (more significant than rs2879096 when tested alone) is diluted when measured in the haplotype.
Notably, these results were strengthened by a further analysis performed that was aimed to assess the sexgenotyping interaction term. 16 Results again confirmed the significant association previously found.
To our knowledge, this is the first study to test whether GRN variability confers an increased susceptibility to develop MS. So far, a risk effect due to SNPs in this gene has been shown in neurodegenerative diseases, including FTLD, 5, 6 Alzheimer's disease 8 and amyotrophic lateral sclerosis. 9 MS is considered mainly an inflammatory disease, but the possibility that PPMS is a primary neurodegenerative disease with variable and secondary demyelination has been recently raised. 17 In vivo experiments support this hypothesis, as the disruption of myelin genome in mice results in late-onset axonal degeneration without significant myelin pathology. 18, 19 These findings strengthen the hypothesis that long-term axonal survival requires trophic support from oligodendrocytes, possibly independent of myelin. 20 Several clinical features are typical of PPMS but not of bout-onset MS, including the clinical presentation (progressive myelopathy vs visual loss), the presence of cognitive impairment and genetic factors (see for review, McDonnell and Hawkins 21 ). Given these particular features, Trapp and Nave 17 hypothesized that, if relapses are secondary in MS pathogenesis, the progression of permanent neurological disability in patients supports a primary, age-related neurodegenerative process similar to that occurring in Alzheimer's disease, and its variants. In line with these findings, our demonstration that GRN variability, besides FTLD, Alzheimer's disease and amyotrophic lateral sclerosis, has a role in PPMS, but not in bout-onset MS, could be conceivable.
Notably, in our replication sample, we did not include patients with the so-called 'transitional MS', 22 who had entered a phase of steady progression without superimposed relapses, but, at some stage in the past, had suffered a single relapse and/or remission.
The effect we described has been observed specifically in male sample. Gender-related differences in MS onset and course have been so far observed. Whereas a significant female predominance exists in relapsingremitting MS, with a ratio of 1:2-3, in PPMS this ratio is Progranulin gene variability in PPMS C Fenoglio et al approximately 1:1. Age at disease onset is higher in PPMS, and the progression is more aggressive in males. 21 Regarding genetic risk factors, sex-related differences have been observed as well. For instance, variants in the macrophage-derived chemokine (MDC/CCL22) encoding gene have been shown to act as protective factors toward the development of MS in males, but not in females. 23 In line with these results, cerebrospinal fluid (CSF) MDC/CCL22 levels were increased in female patients compared with female controls, but not in male sample. 24 Recently, progranulin levels were determined in CSF from 55 MS patients when compared with 35 subjects with noninflammatory neurological diseases, 7 individuals with other inflammatory neurological diseases and 8 controls. No significant differences were found in patients compared with either noninflammatory neurological diseases, other inflammatory neurological diseases or controls even when stratifying according to the disease subtype or gender. 25 However, only 12 CSF samples from PPMS (6 males and 6 females) were available for progranulin determination. Therefore, further studies are needed to clarify whether there is either any alteration of CSF progranulin levels in PPMS or an effect on gender on CSF levels.
Despite the fact that an influence of SNPs studied on the course of the disease is theoretically possible, in this study we did not consider the effect of GRN variability on the rate of progression of disability because a clinical follow-up of all included patients was not available.
Regarding the functional role at the basis of the association observed, in a previous study, which shows that rs4792938 CC genotype is a risk factor for FTLD, 6 a regulatory effect of this SNP on mRNA levels was hypothesized. However, an in silico analysis using the PupaSNP finder suggested that the rs4792938 SNP does not alter either conserved regions that the cellular machinery uses for the correct processing of genes (intron/exon boundaries, splicing enhancers) or predicted transcription factor binding sites. Therefore, we cannot exclude that other variants in LD with those studied are responsible for the observed association. In addition, other genetic or environmental factors specific for each gender could interact with the variants studied to confer the increased risk effect.
To understand better the role of rs4792938, it could be worthy to further investigate its potential regulatory function on GRN mRNA levels, at least in an easy available tissue, such as peripheral blood mononuclear cells.
In conclusion, according to these findings, the GRN TC haplotype represents a susceptibility factor for the development of PPMS in males, whereas GRN CG haplotype has a protective role toward the development of the disease. Nevertheless, a confirmatory study as well as a functional analysis would be needed to get conclusive results.
Materials and methods

Patients and controls
Two independent MS populations were included in the study. All patients underwent a standard battery of examinations, including medical history, physical and neurological examination, screening laboratory test and brain magnetic resonance imaging. All patients with MS fulfilled the McDonald's criteria. 26 The first sample consisted of 354 patients with MS (115 males and 239 females, mean age±s.e.m. 45.7±0.7). They were consecutively recruited at the Multiple Sclerosis Centers of University of Milan, Ospedale Maggiore Policlinico (Milan, Italy) University of Turin (Turin, Italy) and University of Eastern Piedmont, Ospedale Maggiore (Novara, Italy).
The course of MS was described according to Lublin and Reingold 27 as relapsing remitting (n ¼ 285, 84 males and 201 females, age±s.e.m. 43.4±0.7), secondary progressive (n ¼ 50, 20 males and 30 females, age ± s.e.m. 54.7±7.7) or primary progressive (n ¼ 19, 10 males and 9 females, age ± s.e.m. 54.3 ± 5.8).
The control group consisted of 343 subjects (124 males and 219 females, age ± s.e.m. 39.6 ± 0.8).
The second replication sample consisted of 224 patients with PPMS (113 males and 111 females, age±s.e.m. 51.2±1.5). Patients with PPMS were consecutively recruited at Multiple Sclerosis Centers of Scientific Institute San Raffaele (Milan, Italy), Spedali Civili di Brescia (Brescia, Italy), Ospedale di Gallarate (Varese, Italy) and Ospedale S. Carlo (Potenza, Italy).
The control group consisted of 233 subjects matched for ethnic background and gender but not for age (106 males and 127 females, age ± s.e.m. 41.2 ± 2.5). The age of controls did not significantly differ from that of patients, as well as gender distribution (P40.05).
An informed consent to participate in this study was obtained from all participants.
The characteristics of patients and control groups are summarized in Table 5 . 
Progranulin tagging SNPs analysis
For the association analysis, four optimal tagging SNPs covering GRN sequence were chosen by performing a power calculation with the Genetic Power Calculator program (http://pngu.mgh.harvard.edu/~purcell/gpc/) based on sample size, the observed average minor allele frequency and assuming a multiplicative model (rs2879096, rs3785817, rs4792938 and rs9897526; Figure 1 ). Using these parameters, this study provides 80% power to detect an allelic association with Pp0.01 and an OR of at least 1.8, under the assumption of a mean minor allele frequency of markers of 0.2 and that the causal variant would be typed or efficiently tagged with an LD of X0.8. A minimum of one SNP per LD block or two SNPs per haplotype blocks were prioritized. In addition, rs5848, located in the 3 0 -untranslated region and previously shown to influence mRNA transcription through miR-659 regulation, 5 was included in the analysis as well.
Tagging SNPs were analyzed using TaqMan methodology. Each Taqman 5 0 -nuclease assay used 25 ng of genomic DNA as template. Assay-on-demand products, ABI assay IDs: C_15835934_10, C_27482034_10, C_32346749_10, C_2548248_10, C_7452046_10 were used for rs2879096, rs3785817, rs4792938, rs9897526 and rs5848 genotyping, respectively. Probes specific for these variants were labeled with 6-FAM and VIC as reporter dyes and MGB-NFQ (ABI) as quencher. All the assays were performed in 20 ml reactions in 96-well plates using an ABI PRISM 7000 instrument (ABI) as previously described. 28 The genotyping of cases and controls was randomized using plates that contained both cases and controls at different proportions for each plate analyzed.
Statistical analysis
Allelic and genotypic frequencies were obtained by direct counting. To test for Hardy-Weinberg equilibrium, w 2 test was used (http://www.husdyr.kvl.dk/htm/kc/ popgen/genetik/applets/kitest.htm).
Multivariate logistic regression analysis, adjusted for age and gender, was carried out with the SPSS software version 13.0 (SPSS for Windows, Rel. 13.0; SPSS Inc., Chicago, IL, USA), and adjusted ORs with related 95% CI calculated. Significance threshold was set at Po0.05. Haploview software (v4.1) was used to test for LD, haplotype distribution and haplotype gender analysis as well as for the calculation of D' that is based on block definition by Gabriel et al. 15 ( Figures 2a and b ). The bootstrap P-values were subsequently calculated using 100 000 bootstrap samples.
